AI-Assisted Design and Biochemical Optimization of Protein Structures for Enhanced Drug Delivery in Chemotherapy
DOI:
https://doi.org/10.63682/jns.v14i7.5201Keywords:
AI, Biochemical Optimization, Protein Structures, Drug Delivery, Chemotherapy, Cancer treatment.Abstract
Chemotherapy remains the primary treatment for most malignancies; nevertheless, it is troubled by a handful of hindrances like non-specificity of the drug targeting agents, side effects, or actual drug resistance. Thus, protein engineering could be the answer to these problems by designing proteins capable of specific targeting of cancer cells, reducing unwanted drug toxicity, or carrying out controlled drug release. AI, in this regard, encompasses protein structure optimization for accelerated drug delivery and enhancement of the therapeutic efficacy. The present paper looks at AI utilization in protein engineering for drug delivery systems and its influence on chemotherapy, together with the possibility of using these innovations to combat existing challenges and enhance patient outcome.
Downloads
Metrics
References
Abbas, M. et al. (2024) ‘The Role of AI in Drug Discovery’, Chembiochem: A European Journal of Chemical Biology, 25(14), p. e202300816. Available at: https://doi.org/10.1002/cbic.202300816.
Amjad, M.T., Kasi, A. and Chidharla, A. (2023) Cancer Chemotherapy, PubMed. Treasure Island (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK564367/.
Anand, U. et al. (2022) ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’, Genes & Diseases, 10(4), pp. 1367–1401. Available at: https://doi.org/10.1016/j.gendis.2022.02.007.
Bechelli, S. and Delhommelle, J. (2024) ‘AI’s role in pharmaceuticals: Assisting drug design from protein interactions to drug development’, Artificial Intelligence Chemistry, 2(1), p. 100038. Available at: https://doi.org/10.1016/j.aichem.2023.100038.
Gyanani, V., Haley, J.C. and Goswami, R. (2021) ‘Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems’, Pharmaceuticals, 14(9), p. 835. Available at: https://doi.org/10.3390/ph14090835.
Le, M.H.N. et al. (2025) ‘An in-depth review of AI-powered advancements in cancer drug discovery’, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1871(3), p. 167680. Available at: https://doi.org/10.1016/j.bbadis.2025.167680.
Liang, G. et al. (2020) ‘The emerging roles of artificial intelligence in cancer drug development and precision therapy’, Biomedicine & Pharmacotherapy, 128(110255), p. 110255. Available at: https://doi.org/10.1016/j.biopha.2020.110255.
Moingeon, P., Kuenemann, M. and Guedj, M. (2021) ‘Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine’, Drug Discovery Today [Preprint]. Available at: https://doi.org/10.1016/j.drudis.2021.09.006.
Qiu, X. et al. (2024) ‘Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development’, Biomolecules, 14(3), p. 339. Available at: https://doi.org/10.3390/biom14030339.
Rajora, A.K. et al. (2020) ‘Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy’, Pharmaceutics, 12(6), p. 592. Available at: https://doi.org/10.3390/pharmaceutics12060592.
Rasool, A. et al. (2025) ‘Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook’, Frontiers in Oncology, 15. Available at: https://doi.org/10.3389/fonc.2025.1475893.
Rosenkranz, A.A. and Slastnikova, T.A. (2023) ‘Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells’, Pharmaceutics, 15(3), pp. 987–987. Available at: https://doi.org/10.3390/pharmaceutics15030987.
Serrano, D.R. et al. (2024) ‘Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine’, Pharmaceutics, 16(10), p. 1328. Available at: https://doi.org/10.3390/pharmaceutics16101328.
Tyagi, E., Prakash, A. and Bhuyan, R. (2025) ‘Cancer Ther Oncol Int J Enhancing Multi-Targeted Cancer Therapy with AI and Computational Drug Design’, Cancer Ther Oncol Int J, 28(3). Available at: https://doi.org/10.19080/CTOIJ.2025.28.556239.
Yao, J. and Wang, X. (2025) ‘Artificial intelligence in de novo protein design’, Medicine in Novel Technology and Devices, 26, p. 100366. Available at: https://doi.org/10.1016/j.medntd.2025.100366.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
